& GHBP genes, and (2) there is distinct sexual d~~i i o r h p~s m in the erfect of IIYP on GHWGHBP gene transcription. We repon the growth velocities of a11 growth hormone-deficienr, pre-plrbcrrul p:oients tre:~ted since onset of therapy w~t h a daily dose of recombinwt hGl 1 in our clinic. As illu~tratcd ill the table below, our pmients att;~ined adequate growtli velocities wlllle treated with approx~niarely 60% ofthe dow most wldely used. Tlte study populalion consisted of 20 pre-pubenal pmients, 9 of w h o n~ had "org;uiicN and 11 of wlroni ltnd idiopatliic etiologies of thur growl11 honnone deficiency, Aver;~ge age :a onset of tre;itlnelit was 6.6 y e a s . Aver;~ge bone ;bge ~n.~luretion during tre;~tme~it war ,. ~ ~ yra for CTrRT), 1, 2, 3 yrs posl-Rx, and at atla!nmunl ol fmnl hl. The mean change (A) I" ht z-score for CT, CTtRT, and RT ore. respccllvcly. -045, -11.36, 0.U6 a1 end of Ilx; -0 60, -0.46, 0.06 1 yr post-Rx; -0.37, -0.44, -0.05 2 yr prrat-Ri; -029, -0.38, 0 01 3 yr poht-Rx; 0.15 (2 Pla). -079 (16 Pts), -0.68 (6 Rs) fmal hl (ftg). HI decreased a~guficantly at end of Rx for CT (p-0.008) and CTtRT (p=U.OM)2) bul nu1 fur I<T alone (p=026). There was a trend for cunllnued reduction in hl z-score belwccn end ol Rx and tlnnl Irl for RT and CTtRT. Change in hl r-score did not corwlalv w11h age 21 d q n o h~s , sex, or slag" of disease. We conclude that children Rx'rd fur HD with CTLRT uxpvncnce a modest bul signlhcant loss in ht z-score, thal appears to be permanent in those Rx'ed with CT+RT.
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CAN C O S T EFFECTIVENESS O F C R O W T l l IIORMONE UE
M L~ CA (ye:us) a1 llle ~nilaal~on ultrealr~r~il, lo lllc ~C I~C I C I I I gro~~p. wits 11.7t3.5 Ibr buys :uld i0.5+3 2 lor gcrls whilc nx'an DA was 9 2f3.6 lor k,ys :111dX.7*3 lor girls. Mc.m CA w;ts 11.712.1 dnd I0 Sf2.3 wlllle m w a l DA was 9 7+2 2 :lad 8 76f2 1 for boys and girls rcs1xcllvuly. In ll~c oull-dclic~cnl groul). Clra~,ges 10 I'AIl wcrc 1101 currcl.ucd wtlh 1~re-lrv:~lrncnl DA Clt.iligcs . . . 
'TllC EFFECT OF GROWTII 11011M011E (GI11 AIII) IGF-I O N CLOIIOGEIIIC GIIOWTH OF IIEMA'POPOII?I'lC CELLS Ill LEUKEMlC I'A'PICIITS UURIIIC ACTIVE UISLASI: AllU UUllIllC RCMISSIOII. 'rile trulaber of s u r v i v o r s oC cllildllood lcukernia t r e a t e d w i t h GI1 f o r yrowtll C a i l u r e is i2,creaslng. The d e b a t e around Llie d i r e c L o r i n d i r f c L ~c l n L i o~~a l~i p of GI1 and IGF-I t o t h e occurrence o r recurrence o r m.tlrgnancy, e a p c c~i r l l y i n t h e case of GI1 thcrapy i n p a t i e r i t s with leukemia, i s a t i l l ullresulvcd. ACLea we I8ave s t u d i e d
Llle e f C e c t o f GI1 and IGF-I on bulte marrow (Ill+) o f p a t i e n t s witlr a c u t e leukemia (Al.1. and AML) i n a c t i v e d i s e a s e , w e s t u d i e d p a t i e n l s wiut chrot,ic myelogcnous leukemia (CML) i n remlssiurl. W e Itavo st~owli t l m t GI1 i n c r e a s e s b l a s t colony count (UCC) by a mean o f 68% alld 77% a t a GI1 c o n c c n t r a t i o t~s oL 250 and 300 ngjml r e s p e c t i v e l y . IGF-I incre.lscd UCC i n ALL p a t i c l i t s by 3U, 93 and 105% a t 1GL'-l cu~tucnLraLiunr; oC u.05, 0 . 2 3 and 0 . 5 21<jlnll r e s p e c t i v e l y and i n AML p a t i e n t s by 3 7 , GU alld 65% ill t h e presence oC s.lme corrccnLrations. 11, 3 CML ~~a t i~n t s i n remission n gca~,ulocytc-macropl~agc colony Coriniliq a s s a y d i d noL ~e v e a l sLimulaLior~ ui ~> e r i t , l l c r a l blood b l a s t colony Curzni~lg by GI1 o r ICt7-I. 183 c o l > t r a s t With OUT i n vit1.u d a t a ( a s p r e v i o u s l y r e p o r t e d by u s ) t h a t suijqcst LhnL GI1 end IGF-I may promote b l a s t c e l l p r o l i f e r a t i o n , tltis el.fect was n o t seen on c e l l s o b t a i n e d front lcukelilio p a t i e n t s i n r e m i s s i o r~. . .
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-fe;ation, proteoglyaan (PC) s y n t h e s i s , IGF-I and'GtI binding p r o t e i n (GII-Dl') production of c u l t u r e d llPC ( 7 -12 weeks old1 was s t u d i e d . Sirlule c e l l ousuension was o b t a i n e d by k r y p s i n i z a t i o n ( 1 % -f a r 45 1nin.j goncamita -11tly with mechanical I~omogenization. 1-2*10 c e l l s j r n l were seeded and grown f o r 7 days when confluence o c c u r r e d , as well a s p i l e s of c e l l s dnd c a r t i l a g e n o d u l i . At 7 days a s u b c u l t u r e i n UCCM-1 v / o serum was used used t o t e s t t h e response t o exogenous t~ormones. Clio~idrogenic n a t u r e oC c e l l s was c o~~l i~m c r d
by histochem -i c a l s t a i n i n o . d e t e c t i o n of ~~~r t i l d n i n o u s markers bv lu~muno Itistochemistry for c o l l a q e n t y p e I1 and ar i c a n I n c.lse of a l i m i t e d s u~, p l y of c e l l s -i l F c were g r o i n i n d r o p l e t s of hydrated g e l ( a l g i n i c a c i d b e a d s ) . The ~r o l i f e r a t i v e e f f e c t of c e l l s was 65% t o 611. 50% t o IGF-I and 35% t o DIIT. Typical dose response curves were o b t a i n e d wit11 t h e s e t,orrnohes. While endogenous IGF-I was d e t e c t e d I n c u l t u r e no cllange i l l GII-BP l e v e l s was n o t e d . Autocrine paracrilre response to GI1 and UllT i n FttC is suggested. END 
